Biotech SF
San Francisco Bay Area biotech stories.
Friday, August 10, 2012
Genentech's Lucentis approved for diabetic eye disease
Genentech
Inc.'s eye drug
Lucentis
won FDA approval Friday to treat diabetic patients for a blinding disease
. South San Francisco-based Genentech, part of Swiss drug maker Roche, was
recommended last month by a Food and Drug Administration advisory panel
as a treatment for diabetic macular edema.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment